Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway (Q43240643)

17 November 2017

title

Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway (English)

1 reference

17 November 2017

0 references

1 reference

6

1 reference

17 November 2017

Yu-Xiong Feng

1

1 reference

17 November 2017

Jiang-Sha Zhao

2

1 reference

17 November 2017

Jing-Jing Li

3

1 reference

17 November 2017

Tao Wang

4

1 reference

17 November 2017

Shu-Qun Cheng

5

1 reference

17 November 2017

Fudi Wang

7

1 reference

17 November 2017

Xiao-Fan Wang

8

1 reference

17 November 2017

Dong Xie

9

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

17 November 2017

1 reference

17 November 2017

volume

51

1 reference

17 November 2017

issue

2

1 reference

17 November 2017

page(s)

535-544

1 reference

The global health burden of infection-associated cancers in the year 2002

17 November 2017

cites work

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

21 January 2018

1 reference

EphA2 expression is associated with aggressive features in ovarian carcinoma

21 January 2018

1 reference

Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade

21 January 2018

1 reference

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

21 January 2018

1 reference

The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway

21 January 2018

1 reference

EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.

21 January 2018

1 reference

Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma

21 January 2018

1 reference

Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers

21 January 2018

1 reference

Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map

21 January 2018

1 reference

Regulated cleavage of a contact-mediated axon repellent

21 January 2018

1 reference

Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility

21 January 2018

1 reference

Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application

21 January 2018

1 reference

Inhibition of protein kinase B/Akt. implications for cancer therapy

21 January 2018

1 reference

Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.

21 January 2018

1 reference

Nuclear factor-kappaB and liver carcinogenesis

21 January 2018

1 reference

Eph and ephrin signaling in mammary gland morphogenesis and cancer

21 January 2018

1 reference

Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization.

21 January 2018

1 reference

Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth

21 January 2018

1 reference

The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome

21 January 2018

1 reference

Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease

21 January 2018

1 reference

Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease

21 January 2018

1 reference

Tumor necrosis factor (TNF).

21 January 2018

1 reference

Signalling pathways of the TNF superfamily: a double-edged sword

21 January 2018

1 reference

Tumor necrosis factor: how to make a killer molecule tumor-specific?

21 January 2018

1 reference

Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection

21 January 2018

1 reference

EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.

21 January 2018

1 reference

Rac1 mediates intestinal epithelial cell apoptosis via JNK.

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

7 January 2021

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

7 January 2021

Cellular localization of ephrin-A2, ephrin-A5, and other functional guidance cues underlies retinotopic development across species.

1 reference

7 January 2021

Rac1-mediated endocytosis during ephrin-A2- and semaphorin 3A-induced growth cone collapse

1 reference

7 January 2021

Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases

1 reference

7 January 2021

Preoperative and postoperative cytokines in patients with cancer

1 reference

7 January 2021

Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells

1 reference

7 January 2021

Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23313

1 reference

17 November 2017

1 reference